Table 1 Performance of rK39 ICTs on Human and Canine samples from endemic areas in Colombia
From: Evaluation of four rapid diagnostic tests for canine and human visceral Leishmaniasis in Colombia
Parameter evaluated | Human | Canine | ||||||
|---|---|---|---|---|---|---|---|---|
Kalazar Detect™ | ad-bio Leishmania IgG/IgM Combo Rapid Test | Kalazar Detect™ Rapid Test, Canine | DPP® CVL rapid test | |||||
Value | CI 95% | Value | CI 95% | Value | CI 95% | Value | CI 95% | |
Sensitivity | 91.5% | (83.4–95.8) | 91.5% | (83.4–95.8) | 82.9% | (72.38–89.91) | 85.7% | (75.66–92.05) |
Specificity | 89.2% | (80.1–94.4) | 93.2% | (85.1–97.1) | 92.6% | (82.45–97.08) | 79.6% | (67.1–88.23) |
PPV | 90.4% | (82.1–95.0) | 93.8% | (86.19–97.3) | 93.6% | (84.55–97.46) | 84.5% | (74.35–91.12) |
NPV | 90.4% | (81.5–95.3) | 90.8% | (82.2–95.5) | 80.6% | (69.15–88.57) | 81.1% | (68.64–89.41) |
LR (+) | 8.46 | (6.61–10.84) | 13.54 | (9.12–20.08) | 11.19 | (6.80–18.39) | 4.21 | (3.502–5.056) |
LR (−) | 0.096 | (0.072–0.127) | 0.092 | (0.069–0.121) | 0.185 | (0.157–0.219) | 0.179 | (0.146–0.221) |